Influence of intravenous opioid dose on postoperative ileus;La influencia de las dosis de opioides por via intravenosa sobre la oclusión intestinal postoperatoria

Annals of Pharmacotherapy

Volumn 45, Issue 7-8, 2011, Pages 916-923

  Barletta, Jeffrey F ^a   Asgeirsson, Theodor ^b   Senagore, Anthony J ^c  

^a MIDWESTERN UNIVERSITY   (United States)

^b Spectrum Health ^*  (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Colorectal; Dosing; Ileus; Opioid

Indexed keywords

HYDROMORPHONE; OPIATE;

ABDOMINAL DISEASE; ADULT; ARTICLE; CLINICAL PROTOCOL; COLORECTAL SURGERY; COMMUNITY HOSPITAL; DISEASE ASSOCIATION; ELECTIVE SURGERY; EPIDURAL ANESTHESIA; FEMALE; HUMAN; ILEUS; LAPAROSCOPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE ILEUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL TECHNIQUE; TEACHING HOSPITAL;

ADULT; AGE FACTORS; AGED; ANALGESICS, OPIOID; COLORECTAL SURGERY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITALS, COMMUNITY; HOSPITALS, TEACHING; HUMANS; ILEUS; INCIDENCE; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; MALE; MIDDLE AGED; NARCOTICS; PAIN, POSTOPERATIVE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 79960824232     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q041     Document Type: Article

References (24)

1. Senagore AJ. Pathogenesis and clinical and economic consequences of postoperative ileus. Am J Health Syst Pharm 2007;64:S3-7.DOI 10.2146/ajhp070428
2. Asgeirsson T, El-Badawi KI, Mahmood A, Barletta J, Luchtefeld M, Senagore AJ. Postoperative ileus: it costs more than you expect. J Am Coll Surg 2010;210:228-31. DOI 10.1016/j.jamcollsurg.2009.09.028
3. Delaney CP, Zutshi M, Senagore AJ, Remzi FH, Hammel J, Fazio VW. Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum 2003;46:851-9. DOI 10.1097/01.DCR.0000075209.09377.00
4. Delaney CP, Chang E, Senagore AJ, Broder M. Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database. Ann Surg 2008;247:819-24.DOI 10.1097/SLA.0b013e31816d950e
5. Augestad KM, Delaney CP. Postoperative ileus: impact of pharmacological treatment, laparoscopic surgery and enhanced recovery pathways. World J Gastroenterol 2010;16:2067-74.
6. Artinyan A, Nunoo-Mensah JW, Balasubramaniam S, et al. Prolonged postoperative ileus-definition, risk factors, and predictors after surgery. World J Surg 2008;32:1495-500. DOI 10.1007/s00268-008-9491-2
7. Cali RL, Meade PG, Swanson MS, Freeman C. Effect of morphine and incision length on bowel function after colectomy. Dis Colon Rectum 2000;43:163-8.
8. Goettsch WG, Sukel MP, van der Peet DL, van Riemsdijk MM, Herings RM. In-hospital use of opioids increases rate of coded postoperative paralyt ic ileus. Pharmacoepidemiol Drug Saf 2007;16:668-74.DOI 10.1002/pds.133
9. Manara L, Bianchetti A. The central and peripheral influences of opioids on gastrointestinal propulsion. Annu Rev Pharmacol Toxicol 1985;25: 249-73. DOI 10.1146/annurev.pa.25.040185.001341
10. Senagore AJ. Laparoscopic sigmoid colectomy for diverticular disease. Surg Clin North Am 2005;85:19-24, vii. DOI 0.1016/j.suc.2004.09.007
11. American Pain Society. Principles of analgesic use in the treatment of acute pain and chronic cancer pain. 5th ed. Glenview, IL: American Pain Society, 2003.
12. Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med 2003;26:172-81.
13. Chang SS, Baumgartner RG, Wells N, Cookson MS, Smith JA Jr. Causes of increased hospital stay after radical cystectomy in a clinical pathway setting. J Urol 2002;167:208-211.
14. Collins TC, Daley J, Henderson WH, Khuri SF. Risk factors for prolonged length of stay after major elective surgery. Ann Surg 1999;230:251-9.
15. Bauer AJ, Boeckxstaens GE. Mechanisms of postoperative ileus. Neurogas-troenterol Motil 2004;16(suppl 2):54-60.DOI 10.1111/j.1743-3150.2004.00558.x
16. Wolff BG, Weese JL, Ludwig KA, et al. Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection. J Am Coll Surg 2007;204:609-16. DOI 10.1016/j.jamcollsurg.2007.01.041
17. Frantzides CT, Condon RE, Schulte WJ, Cowles V. Effects of morphine on colonic myoelectric and motor activity in subhuman primates. Am J Physiol 1990;258:G247-52.
18. Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil 2004;16(suppl 2):17-28.DOI 10.1111/j.1743-3150.2004.00554.x
19. Iyer S, Saunders WB, Stemkowski S. Economic burden of postoperative ileus associated with colectomy in the United States. J Manag Care Pharm 2009;15:485-94.
20. Ahmed J, Lim M, Khan S, McNaught C, Macfie J. Predictors of length of stay in patients having elective colorectal surgery within an enhanced recovery protocol. Int J Surg 2010;8:628-32. DOI 10.1016/j.ijsu.2010.07.294
21. Delaney C P, Weese JL, Hyman NH, et al. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery. Dis Colon Rectum 2005;48:1114-25. DOI 10.1007/s10350-005-0035-7
22. Ludwig K, Enker WE, Delaney CP, et al. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvi-mopan and placebo with a standardized accelerated postoperative care pathway. Arch Surg 2008;143:1098-105. DOI 10.1001/archsurg.143.11.1098
23. Viscusi ER, Goldstein S, Witkowski T, et al. Alvimopan, a peripherally acting mu- opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study. Surg Endosc 2006;20:64-70.DOI 10.1007/s00464-005-0104-y
24. Wolff BG, Michelassi F, Gerkin TM, et al. Alvimopan, a novel, peripher ally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg 2004;240:728-34.